COVID booster shots increase immunity, trial showsA trial of booster vaccinations to protect against COVID-19 has shown that the jab significantly strengthens the body’s Share XCOVID booster shots increase immunity, trial showshttps://pharmaphorum.com/news/covid-booster-shots-increase-immunity-trial-shows/
Pharma pledges rapid response to Omicron COVID variantWith governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Share XPharma pledges rapid response to Omicron COVID varianthttps://pharmaphorum.com/news/pharma-pledges-rapid-response-to-omicron-covid-variant/
Novavax gets first authorisation for its COVID-19 jabNovavax has been granted its first emergency use authorisation in Indonesia for COVID-19 vaccine NVX-CoV2373, and expects other Share XNovavax gets first authorisation for its COVID-19 jabhttps://pharmaphorum.com/news/novavax-gets-first-authorisation-for-its-covid-19-jab/
Novavax files its COVID jab to WHO for emergency use listingNovavax and its partner Serum Institute of India have applied to the World Health Organization for an emergency Share XNovavax files its COVID jab to WHO for emergency use listinghttps://pharmaphorum.com/news/novavax-files-its-covid-jab-to-who-for-emergency-use-listing/
Amnesty says COVID jab producers are causing human rights crisisAmnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies for not agreeing Share XAmnesty says COVID jab producers are causing human rights crisishttps://pharmaphorum.com/news/amnesty-says-covid-jab-producers-are-causing-human-rights-crisis/
Novavax unveils phase 3 COVID jab data, but has it missed the boat in US?The top-line phase 3 data for Novavax’ COVID-19 vaccine look good, with a 90% overall efficacy rate, but Share XNovavax unveils phase 3 COVID jab data, but has it missed the boat in US?https://pharmaphorum.com/news/novavax-unveils-phase-3-covid-jab-data-but-has-it-missed-the-boat-in-us/
UK booster trial will test value of third COVID jab doseAll seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will Share XUK booster trial will test value of third COVID jab dosehttps://pharmaphorum.com/news/uk-booster-trial-will-test-value-of-third-covid-jab-dose/
Novavax delays COVID vaccine filings until Q3Novavax has finally provided some clarity about when its long-awaited COVID-19 vaccine will be ready, saying regulatory filings Share XNovavax delays COVID vaccine filings until Q3https://pharmaphorum.com/news/novavax-delays-covid-vaccine-filings-until-q3-blaming-lack-of-manufacturing-data/
UK Vaccine Taskforce head lifts lid on Novavax dealThe UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its Share XUK Vaccine Taskforce head lifts lid on Novavax dealhttps://pharmaphorum.com/news/novavax-developed-vaccine-in-uk-because-of-rd-opportunities/
